Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year

1989

Stage

IPO | IPO

Total Raised

$5.8M

Date of IPO

1/6/1993

About Erox

Developer of fragrances containing human pheromones for use in perfumes and cosmetic products. Pheromones are biochemical products known to play a vital role in the mating process of various species of animals. In humans, pheromones affect the hypothalamus, the part of the brain that assists in regulating appetite, anger, sex drive, and temperature. The company believes that pheromones affect the brain and nervous system through small cavities inside the nasal passages.

Erox Headquarter Location

Fremont, California, 94536,

United States

(510)226-6874

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.